OTC: JCRRF - JCR Pharmaceuticals Co., Ltd.

Yield per half year: 0%
Dividend yield: 0%
Sector: Healthcare

Share chart JCR Pharmaceuticals Co., Ltd.

Extended chart Simple chart
Financial Markets by TradingView

About JCR Pharmaceuticals Co., Ltd.

JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease.

more details
The company also develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells medical devices and laboratory instruments. The company has a collaboration agreement with Angelini Pharma for the development of novel biologic therapies. JCR Pharmaceuticals Co., Ltd. was incorporated in 1975 and is headquartered in Ashiya, Japan.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 324.73
Дивиденд ао 0.0661
Сайт https://www.jcrpharm.co.jp
Цена ао 4.57
Change price per day: 0% (4.57)
Change price per week: 0% (4.57)
Change price per month: 0% (4.57)
Change price per 3 month: 0% (4.57)
Change price per half year: 0% (4.57)
Change price per year: -26.29% (6.2)
Change price per year to date: 0% (4.57)
All parameters

Underestimation

Title Value Grade
P/S 4.95 3
P/BV 3.24 5
P/E 45.05 3
EV/EBITDA 24.02 5
Total: 5.63

Efficiency

Title Value Grade
ROA, % 3.97 1
ROE, % 7.23 2
Total: 3

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0.7 7
Total: 3.37

Debt

Title Value Grade
Debt/EBITDA 3.05 4
Total: 6.2

Growth impulse

Title Value Grade
Yield Revenue, % -98.66 0
Yield Ebitda, % -98.95 0
Yield EPS, % -99.09 0
Total: 0
More

Institutions Volume Share, %
Legato Capital Management LLC 10901 0.01



Head Job title Payment Year of birth
Mr. Shin Ashida Chairman, CEO & President N/A 1943 (82 years)
Yoshihiro Ota Director of Accounting Department & Corporate Strategy Department (Finance) N/A
Yutaka Honda Sr. Corp. Off, Exec. Dir. of Admin Div. and Dir. of Gen. Affairs & HR Planning Dept. N/A
Hiroyuki Fukuya Director of Legal Affairs Department - Administration Division N/A
Toru Ashida Senior VP of Sales & Administration, Executive Director of Sales Division and Director N/A 1968 (57 years)
Ryutaro Makino Director of Marketing Dept. & Group Manager of Product Planning - Marketing Dept. for Sales Div. N/A
Katsuya Nishino Executive Vice President N/A 1956 (69 years)
Hiroshi Yoshimoto Senior Advisor N/A 1951 (74 years)
Takayo Egawa Corporate Officer & Director of International Affairs Office N/A
Mr. Hiroyuki Sonoda Ph.D. VP of Research & Corporate Strategy, Executive Director of Research Division and Director N/A 1978 (47 years)

Address: Japan, Ashiya -, 3-19 Kasuga-cho - open in Google maps, open in Yandex maps
Website: https://www.jcrpharm.co.jp